Angelo De Rosa

Front-end business and innovation leader in medical device technologies. Vice President & General Manager for Cardiac Devices and Electrophysiology in EMEA at Boston Scientific. Previously in charge of Strategy and Business Development at Medtronic across Europe, Middle East, Africa and Canada.

Angelo brings over 20 years of international leadership experience in the medical device business, covering General Management, Business Development, M&A, Sales and Marketing, Clinical  responsibilities in diversified geographic areas.

He is also an entrepreneur, founder of NayaMed International and passionate about disruptive business models in healthcare. Advisory Board member of the Ambient Assisted Living (AAL) Joint Programme. Past President and member of the Advisory Council of the HealthTech Summit.

Angelo holds a Biomedical Engineer Degree from the University of Pisa and an MBA from Politecnico di Milano, Italy. Continuous education from IMD in Lausanne and Wharton Business School, Pennsylvania, certified Strategy Management Officer.

This blog is part of a blog series that showcases the medtech role in the different phases of the COVID-19 pandemic. Read here more COVID-19 related blogs. More info on MedTech Europe's info hub . This time last year, I wrote an article on digital technologies for MedTech Week, focused on the importance of digital diagnosis. I have always been a keen advocate of digital and combining my passions for medicine and engineering is what led me here. Last year’s article was from a pre-COVID world and no-one had any idea what was around the corner. We are now in a completely different place and I wanted to relook at this and how digital tools, such as remote management, have come into the spotlight and even accelerated in use. Considering the increasing pressure on healthcare systems everywhere, digital was already becoming a mainstream solution. Who could have known just how great the need would become to keep vulnerable patients out of hospital and away from COVID? Remote management has been part of our offering for some time and key to what we do. Alongside the excellent data and very positive feedback from doctors, we’re seeing an increased demand for use. One of our diagnostic tools allows physicians to detect the risk of heart failure symptoms worsening up to 30 days in advance, so patients can be contacted and provided with support on how to manage symptoms to keep them out of hospital. Which is more important than ever for vulnerable people with long-term chronic conditions such as heart failure. When the storm began in March, there was a lot to think about as we adjusted to lockdowns, social distancing and new ways of working. We all had to think about how to adapt and most importantly, how to support customers?...